Drug intelligence / Profile preview

β-hydroxy-β-methylbutyric acid

Development stage
Phase 1
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

β-Hydroxy-β-methylbutyric acid (HMB) is a naturally occurring metabolite of the essential amino acid leucine. It is produced in small amounts in the human body and can also be taken as a dietary supplement. HMB is primarily used to promote muscle growth and prevent muscle breakdown (catabolism), especially in individuals undergoing resistance training or experiencing muscle wasting due to aging or chronic illness. Mechanistically, HMB stimulates protein synthesis via activation of the PI3K/Akt/mTOR pathway and inhibits protein degradation by suppressing the ubiquitin-proteasome proteolytic pathway. It may also have neurotrophic effects and improve vascular endothelial function[4][5][8]. HMB is available over-the-counter as both a free acid (HMB-FA) and as calcium salt (calcium β-hydroxy-β-methylbutyrate). It has been included in medical foods for patients with cachexia or sarcopenia[5][8].

Brand names
CaHMB 3000CaHMB3000CaHMB-3000
Other names
hydroxymethylbutyratebeta-hydroxy-beta-methylbutyrateHMB free acid3-hydroxy-3-methylbutanoic acid
02

Targets

EIF2AK2 (Interferon-induced protein kinase R)

Beyond the preview

Go deeper on β-hydroxy-β-methylbutyric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β-hydroxy-β-methylbutyric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call